Personal information

Activities

Employment (2)

Gastroenterology Center of Connecticut: Hamden, CT, US

2011-11-01 to present | Attending Gastroenterologist (Gastroenterology)
Employment
Source: Self-asserted source
Paul Feuerstadt

Danbury Hospital: Danbury, CT, US

2010-07-10 to 2011-10-24 | Attending Physician (Gastroenterology)
Employment
Source: Self-asserted source
Paul Feuerstadt

Education and qualifications (4)

Montefiore Hospital and Medical Center: Bronx, NY, US

2007-07-01 to 2010-06-30 | Fellow (Gastroenterology)
Education
Source: Self-asserted source
Paul Feuerstadt

NewYork-Presbyterian Hospital: New York, NY, US

2004-06-15 to 2007-06-30 | Categorical Resident (Internal Medicine)
Education
Source: Self-asserted source
Paul Feuerstadt

Joan and Sanford I Weill Medical College of Cornell University: New York, NY, US

2000-08-15 to 2004-06-15 | MD (Medical School)
Education
Source: Self-asserted source
Paul Feuerstadt

University of Pennsylvania: Philadelphia, PA, US

1996-09-01 to 2000-06-01 | Bachelor of Arts (School of Arts and Sciences)
Education
Source: Self-asserted source
Paul Feuerstadt

Works (24)

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection

Clinical Infectious Diseases
2025-02-05 | Journal article
Contributors: Paul Feuerstadt; Teena Chopra; Whitfield Knapple; Nicholas W Van Hise; Erik R Dubberke; Brian Baggott; Beth Guthmueller; Lindy Bancke; Michael Gamborg; Theodore S Steiner et al.
Source: check_circle
Crossref

Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS

Inflammatory Bowel Diseases
2025-01-25 | Journal article
Contributors: Jessica R Allegretti; Paul Feuerstadt; Whitfield L Knapple; Robert Orenstein; Philippe Pinton; Alexander Sheh; Sahil Khanna
Source: check_circle
Crossref

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection

Infectious Diseases and Therapy
2024-01 | Journal article
Contributors: Paul Feuerstadt; Jessica R. Allegretti; Erik R. Dubberke; Amy Guo; Adam Harvey; Min Yang; Viviana Garcia-Horton; Mirko Fillbrunn; Glenn Tillotson; Lindy L. Bancke et al.
Source: check_circle
Crossref

Efficacy and safety of prucalopride in patients with chronic idiopathic constipation stratified by age, body mass index, and renal function: a post hoc analysis of phase III and IV, randomized, placebo-controlled clinical studies

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
Contributors: Anthony Lembo; Kyle Staller; Mena Boules; Paul Feuerstadt; William Spalding; André Gabriel; Ashraf Youssef; Yunlong Xie; Brian Terreri; Brooks D. Cash
Source: check_circle
Crossref

Retrospective subgroup analysis of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infection

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
Contributors: Whitfield L. Knapple; David S. Yoho; Alexander Sheh; Joan Thul; Paul Feuerstadt
Source: check_circle
Crossref

First Clostridioides difficile Recurrence Is Highest Following Concomitant Antimicrobial Administration During and Within 30 Days of Treatment

Digestive Diseases and Sciences
2023-11 | Journal article
Contributors: Abdelkader Chaar; John Damianos; Rabia Rizwan; Houssam Al-Nahhas; Muhammad Sohail Mansoor; Prabin Sharma; Umer Malik; Paul Feuerstadt
Source: check_circle
Crossref

Where does RBX2660 fit within clinical practice?

Expert Review of Anti-infective Therapy
2023-03-04 | Journal article
Contributors: Paul Feuerstadt
Source: check_circle
Crossref

Safety of fecal microbiota, live-jslm (REBYOTAâ„¢) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Therapeutic Advances in Gastroenterology
2023-01 | Journal article
Contributors: Christine Lee; Thomas Louie; Lindy Bancke; Beth Guthmueller; Adam Harvey; Paul Feuerstadt; Sahil Khanna; Robert Orenstein; Erik R. Dubberke
Source: check_circle
Crossref

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection

Digestive Diseases and Sciences
2022-07 | Journal article
Contributors: Paul Feuerstadt; Olga C. Aroniadis; Felicia L. Svedlund; Mariana Garcia; Laura Stong; Mena Boules; Sahil Khanna
Source: check_circle
Crossref

Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection

Therapeutic Advances in Gastroenterology
2021-01 | Journal article
Contributors: Abdelkader Chaar; Paul Feuerstadt
Source: check_circle
Crossref

Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection

Digestive Diseases and Sciences
2020-02-22 | Journal article
Contributors: Paul Feuerstadt; Simon J. Hong; Lawrence J. Brandt
Source: check_circle
Crossref

Review article: the pharmacological causes of colon ischaemia

Alimentary Pharmacology & Therapeutics
2019-01 | Journal article
Contributors: Ziga Vodusek; Paul Feuerstadt; Lawrence J. Brandt
Source: check_circle
Crossref

ACG clinical guideline: Epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI)

American Journal of Gastroenterology
2015 | Journal article
EID:

2-s2.0-84920626867

Contributors: Brandt, L.J.; Feuerstadt, P.; Longstreth, G.F.; Boley, S.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

The evolution of Urban C. difficile infection (CDI): CDI in 2009-2011 Is less severe and has better outcomes Than CDI in 2006-2008

American Journal of Gastroenterology
2014 | Journal article
EID:

2-s2.0-84905595601

Contributors: Feuerstadt, P.; Das, R.; Brandt, L.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Diverticular disease of the colon does not increase risk of Repeat C. difficile infection

Journal of Clinical Gastroenterology
2013 | Journal article
EID:

2-s2.0-84876418463

Contributors: Feuerstadt, P.; Das, R.; Brandt, L.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Response to Fujita

American Journal of Gastroenterology
2011 | Journal article
EID:

2-s2.0-79953767190

Contributors: Feuerstadt, P.; Brandt, L.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Response to longstreth

American Journal of Gastroenterology
2011 | Journal article
EID:

2-s2.0-79751509514

Contributors: Brandt, L.J.; Feuerstadt, P.; Blaszka, M.C.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: A study of 313 cases supported by histology

American Journal of Gastroenterology
2010 | Journal article
EID:

2-s2.0-77957833795

Contributors: Brandt, L.J.; Feuerstadt, P.; Blaszka, M.C.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Colon ischemia: Recent insights and advances

Current Gastroenterology Reports
2010 | Journal article
EID:

2-s2.0-77958187952

Contributors: Feuerstadt, P.; Brandt, L.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Effectiveness of hepatitis c treatment with pegylated interferon and ribavirin in urban minority patients

Hepatology
2010 | Journal article
EID:

2-s2.0-77950602777

Contributors: Feuerstadt, P.; Bunim, A.L.; Garcia, H.; Karlitz, J.J.; Massoumi, H.; Thosani, A.J.; Pellecchia, A.; Wolkoff, A.W.; Gaglio, P.J.; Reinus, J.F.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease

American Journal of Gastroenterology
2010 | Journal article
EID:

2-s2.0-77956340254

Contributors: Das, R.; Feuerstadt, P.; Brandt, L.J.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Submaximal effort tolerance as a predictor of all-cause mortality in patients undergoing cardiac rehabilitation

Clinical Cardiology
2007 | Journal article
EID:

2-s2.0-34249075997

Contributors: Feuerstadt, P.; Chai, A.; Kligfield, P.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Incremental improvement in submaximal effort capacity during the third month of cardiac rehabilitation

Journal of Cardiopulmonary Rehabilitation
2005 | Journal article
EID:

2-s2.0-23844448346

Contributors: Chai, A.; Feuerstadt, P.; Kligfield, P.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Effect of age and gender on heart rate recovery after submaximal exercise during cardiac rehabilitation in patients with angina pectoris, recent acute myocardial infarction, or coronary bypass surgery

American Journal of Cardiology
2003 | Journal article
EID:

2-s2.0-0141669009

Contributors: Kligfield, P.; McCormick, A.; Chai, A.; Jacobson, A.; Feuerstadt, P.; Hao, S.C.
Source: Self-asserted source
Paul Feuerstadt via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for Clinical infectious diseases : (1)